# Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL

> **NCT04168788** · NA · UNKNOWN · sponsor: **University Hospital, Angers** · enrollment: 150 (estimated)

## Conditions studied

- Hepatic Veno-Occlusive Disease
- Nephroblastoma
- Acute Lymphoblastic Leukemia

## Interventions

- **OTHER:** Blood test for genetic analysis

## Key facts

- **NCT ID:** NCT04168788
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2019-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04168788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04168788, "Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04168788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*